Drugmakers Must Plan Ahead to Convert Labeling Content to SPL, Experts Say

Drug Industry Daily
KEYWORDS FDA / Technology
A A

Switching to the structured product labeling (SPL) format for labeling content submissions will require pharmaceutical manufacturers to make some adjustments in their IT infrastructures, experts said.

To View This Article:

Login

Subscribe To Drug Industry Daily